Gavin D Perkins1,2, Dipesh Mistry1, Simon Gates1,3, Fang Gao2,3, Catherine Snelson4, Nicholas Hart5, Luigi Camporota5, James Varley6, Coralie Carle7, Elankumaran Paramasivam8, Beverley Hoddell1, Daniel F McAuley9, Timothy S Walsh10, Bronagh Blackwood9, Louise Rose11,12, Sarah E Lamb13, Stavros Petrou1, Duncan Young13, Ranjit Lall1. 1. Warwick Clinical Trials Unit, University of Warwick, Coventry, England. 2. Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England. 3. Cancer Research United Kingdom Clinical Trials Unit, University of Birmingham, Birmingham, England. 4. Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, England. 5. Guy's and St Thomas' NHS Foundation Trust, London, England. 6. Addenbrooke's Hospital, Cambridge, England. 7. Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, England. 8. Leeds Teaching Hospitals, Leeds, England. 9. Queen's University of Belfast, Belfast, Northern Ireland. 10. University of Edinburgh, Edinburgh, Scotland. 11. University of Toronto, Toronto, Ontario, Canada. 12. Kings College London, London, England. 13. University of Oxford, Oxford, England.
Abstract
Importance: In adults in whom weaning from invasive mechanical ventilation is difficult, noninvasive ventilation may facilitate early liberation, but there is uncertainty about its effectiveness in a general intensive care patient population. Objective: To investigate among patients with difficulty weaning the effects of protocolized weaning with early extubation to noninvasive ventilation on time to liberation from ventilation compared with protocolized invasive weaning. Design, Setting, and Participants: Randomized, allocation-concealed, open-label, multicenter clinical trial enrolling patients between March 2013 and October 2016 from 41 intensive care units in the UK National Health Service. Follow-up continued until April 2017. Adults who receivedinvasive mechanical ventilationfor more than 48 hours and in whom a spontaneous breathing trial failed were enrolled. Interventions: Patients were randomized to receive either protocolized weaning via early extubation to noninvasive ventilation (n = 182) or protocolized standard weaning (continued invasive ventilation until successful spontaneous breathing trial, followed by extubation) (n = 182). Main Outcomes and Measures: Primary outcome was time from randomization to successful liberation from all forms of mechanical ventilation among survivors, measured in days, with the minimal clinically important difference defined as 1 day. Secondary outcomes were duration of invasive and total ventilation (days), reintubation or tracheostomy rates, and survival. Results: Among 364 randomized patients (mean age, 63.1 [SD, 14.8] years; 50.5% male), 319 were evaluable for the primary effectiveness outcome (41 died before liberation, 2 withdrew, and 2 were discharged with ongoing ventilation). The median time to liberation was 4.3 days in the noninvasive group vs 4.5 days in the invasive group (adjusted hazard ratio, 1.1; 95% CI, 0.89-1.40). Competing risk analysis accounting for deaths had a similar result (adjusted hazard ratio, 1.1; 95% CI, 0.86-1.34). The noninvasive group received less invasive ventilation (median, 1 day vs 4 days; incidence rate ratio, 0.6; 95% CI, 0.47-0.87) and fewer total ventilator days (median, 3 days vs 4 days; incidence rate ratio, 0.8; 95% CI, 0.62-1.0). There was no significant difference in reintubation, tracheostomy rates, or survival. Adverse events occurred in 45 patients (24.7%) in the noninvasive group compared with 47 (25.8%) in the invasive group. Conclusions and Relevance: Among patients requiringmechanical ventilation in whom a spontaneous breathing trial had failed, early extubation to noninvasive ventilation did not shorten time to liberation from any ventilation. Trial Registration: ISRCTN Identifier: ISRCTN15635197.
RCT Entities:
Importance: In adults in whom weaning from invasive mechanical ventilation is difficult, noninvasive ventilation may facilitate early liberation, but there is uncertainty about its effectiveness in a general intensive care patient population. Objective: To investigate among patients with difficulty weaning the effects of protocolized weaning with early extubation to noninvasive ventilation on time to liberation from ventilation compared with protocolized invasive weaning. Design, Setting, and Participants: Randomized, allocation-concealed, open-label, multicenter clinical trial enrolling patients between March 2013 and October 2016 from 41 intensive care units in the UK National Health Service. Follow-up continued until April 2017. Adults who received invasive mechanical ventilation for more than 48 hours and in whom a spontaneous breathing trial failed were enrolled. Interventions: Patients were randomized to receive either protocolized weaning via early extubation to noninvasive ventilation (n = 182) or protocolized standard weaning (continued invasive ventilation until successful spontaneous breathing trial, followed by extubation) (n = 182). Main Outcomes and Measures: Primary outcome was time from randomization to successful liberation from all forms of mechanical ventilation among survivors, measured in days, with the minimal clinically important difference defined as 1 day. Secondary outcomes were duration of invasive and total ventilation (days), reintubation or tracheostomy rates, and survival. Results: Among 364 randomized patients (mean age, 63.1 [SD, 14.8] years; 50.5% male), 319 were evaluable for the primary effectiveness outcome (41 died before liberation, 2 withdrew, and 2 were discharged with ongoing ventilation). The median time to liberation was 4.3 days in the noninvasive group vs 4.5 days in the invasive group (adjusted hazard ratio, 1.1; 95% CI, 0.89-1.40). Competing risk analysis accounting for deaths had a similar result (adjusted hazard ratio, 1.1; 95% CI, 0.86-1.34). The noninvasive group received less invasive ventilation (median, 1 day vs 4 days; incidence rate ratio, 0.6; 95% CI, 0.47-0.87) and fewer total ventilator days (median, 3 days vs 4 days; incidence rate ratio, 0.8; 95% CI, 0.62-1.0). There was no significant difference in reintubation, tracheostomy rates, or survival. Adverse events occurred in 45 patients (24.7%) in the noninvasive group compared with 47 (25.8%) in the invasive group. Conclusions and Relevance: Among patients requiring mechanical ventilation in whom a spontaneous breathing trial had failed, early extubation to noninvasive ventilation did not shorten time to liberation from any ventilation. Trial Registration: ISRCTN Identifier: ISRCTN15635197.
Authors: A Esteban; I Alía; M J Tobin; A Gil; F Gordo; I Vallverdú; L Blanch; A Bonet; A Vázquez; R de Pablo; A Torres; M A de La Cal; S Macías Journal: Am J Respir Crit Care Med Date: 1999-02 Impact factor: 21.405
Authors: Timothy D Girard; Waleed Alhazzani; John P Kress; Daniel R Ouellette; Gregory A Schmidt; Jonathon D Truwit; Suzanne M Burns; Scott K Epstein; Andres Esteban; Eddy Fan; Miguel Ferrer; Gilles L Fraser; Michelle Ng Gong; Catherine L Hough; Sangeeta Mehta; Rahul Nanchal; Sheena Patel; Amy J Pawlik; William D Schweickert; Curtis N Sessler; Thomas Strøm; Kevin C Wilson; Peter E Morris Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405
Authors: Christophe Girault; Michael Bubenheim; Fekri Abroug; Jean Luc Diehl; Souheil Elatrous; Pascal Beuret; Jack Richecoeur; Erwan L'Her; Gilles Hilbert; Gilles Capellier; Antoine Rabbat; Mohamed Besbes; Claude Guérin; Philippe Guiot; Jacques Bénichou; Guy Bonmarchand Journal: Am J Respir Crit Care Med Date: 2011-09-15 Impact factor: 21.405
Authors: D J Cook; S D Walter; R J Cook; L E Griffith; G H Guyatt; D Leasa; R Z Jaeschke; C Brun-Buisson Journal: Ann Intern Med Date: 1998-09-15 Impact factor: 25.391
Authors: J-M Boles; J Bion; A Connors; M Herridge; B Marsh; C Melot; R Pearl; H Silverman; M Stanchina; A Vieillard-Baron; T Welte Journal: Eur Respir J Date: 2007-05 Impact factor: 16.671
Authors: M Dietrich; C J Reuß; C Beynon; A Hecker; C Jungk; D Michalski; C Nusshag; K Schmidt; M Bernhard; T Brenner; M A Weigand Journal: Anaesthesist Date: 2019-11 Impact factor: 1.041
Authors: Padmanabhan Ramnarayan; Alvin Richards-Belle; Laura Drikite; Michelle Saull; Izabella Orzechowska; Robert Darnell; Zia Sadique; Julie Lester; Kevin P Morris; Lyvonne N Tume; Peter J Davis; Mark J Peters; Richard G Feltbower; Richard Grieve; Karen Thomas; Paul R Mouncey; David A Harrison; Kathryn M Rowan Journal: JAMA Date: 2022-04-26 Impact factor: 157.335
Authors: Iftekhar Khan; Mandy Maredza; Melina Dritsaki; Dipesh Mistry; Ranjit Lall; Sarah E Lamb; Keith Couper; Simon Gates; Gavin D Perkins; Stavros Petrou Journal: Pharmacoecon Open Date: 2020-12
Authors: Joyce Yeung; Keith Couper; Elizabeth G Ryan; Simon Gates; Nick Hart; Gavin D Perkins Journal: Intensive Care Med Date: 2018-10-31 Impact factor: 17.440